| CASE REPORT |
|
| Year : 2022 | Volume
: 2
| Issue : 1 | Page : 14-16 |
|
|
Novel diagnosis of systemic lupus erythematosus after first dose of COVID-19 vaccination
Khalid S Alshahrani, Jorge Sanchez-Guerrero
Division of Rheumatology, Sinai Health System/University Health Network, University of Toronto, Ontario, Canada
Correspondence Address:
Dr. Jorge Sanchez-Guerrero
60 Murray St. 2-005. Toronto, ON, M5T 3L9
Canada
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/ara.ara_10_21
|
|
|
In the literature, there are two case reports of new diagnoses of systemic lupus erythematosus including a patient with early-onset of class V nephritis; both cases had received the AstraZeneca Vaccine. There are also several cases-reports of autoimmune disease flares after receiving the first or the second dose of the different COVID-19 vaccinations. The severity of the disease flares, the number of doses after which the disease flared, and the approach to control the flare manifestations vary across the reports. The majority of the case reports focus on disease activation rather than a newly diagnosed autoimmune disease after receiving the COVID-19 vaccines. Here, we report a young female with new-onset systemic lupus erythematosus manifesting with arthritis, cutaneous manifestations, and fever 5 days after the first dose of (ChAdOx1 nCoV-19) vaccine.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
